ONCY:NASDAQ
Oncolytics Biotech Inc
US$0,63
arrow_downward
-1,59%(-0,010) 1D
US$0,65
arrow_upward
+3,00% (+0,019)todayPre-market
Closed: 2 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
US$0,65
High
US$0,65
Low
US$0,62
Mkt. cap
80,46 ລ້ານ
Avg. vol.
969,28 ພັນ
Volume
0,00
52-wk high
US$1,42
52-wk low
US$0,62
Beta
1,15
Shares outstanding
127,51 ລ້ານ
No. of employees
29
Open
US$0,65
High
US$0,65
Low
US$0,62
Mkt. cap
80,46 ລ້ານ
Avg. vol.
969,28 ພັນ
Volume
0,00
52-wk high
US$1,42
52-wk low
US$0,62
Beta
1,15
Shares outstanding
127,51 ລ້ານ
No. of employees
29
News stories
From web sources and news partners
MarketBeat
·
14 ນາທີກ່ອນ
Principal Financial Group, Inc. (NASDAQ:PFG) Stock Now Rated "Hold" by Wall Street Analysts
Benzinga
·
19 ນາທີກ່ອນ
Nasdaq Jumps 300 Points Following Jobs Data: Investor Sentiment Improves, Greed Index Remains in ‘Fear’ Z
Briefs Finance
·
1 ຊົ່ວໂມງກ່ອນ
OKX and ICE Launch Tokenized NYSE Stocks
Yahoo Finance
·
1 ຊົ່ວໂມງກ່ອນ
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
Headquartersຄັລກາຣີ, ອັລເບີທາ, ແຄນາດາ
SectorBiotechnology
Websiteoncolyticsbiotech.com